North America Hemostats Market Size & Forecast to 2022-2028

North America Hemostats Market Size, Share & Industry Trends Analysis Report By Application, By Formulation (Matrix & Gel, Sheet & Pad, Powder, Sponge, and Others), By Type, By Country and Growth Forecast, 2022 - 2028

Published Date: July-2022 | Number of Pages: 92 | Format: PDF | Report ID: KBV-19204

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Hemostats Market, by Application
1.4.2 North America Hemostats Market, by Formulation
1.4.3 North America Hemostats Market, by Type
1.4.4 North America Hemostats Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. North America Hemostats Market by Application
3.1 North America Orthopedic Surgery Market by Country
3.2 North America General Surgery Market by Country
3.3 North America Neurological Surgery Market by Country
3.4 North America Cardiovascular Surgery Market by Country
3.5 North America Reconstructive Surgery Market by Country
3.6 North America Gynecological Surgery Market by Country
3.7 North America Others Market by Country

Chapter 4. North America Hemostats Market by Formulation
4.1 North America Matrix & Gel Market by Country
4.2 North America Sheet & Pad Market by Country
4.3 North America Powder Market by Country
4.4 North America Sponge Market by Country
4.5 North America Others Market by Country

Chapter 5. North America Hemostats Market by Type
5.1 North America Thrombin Based Market by Country
5.2 North America Combination Market by Country
5.3 North America Oxidized Regenerated Cellulose Based Market by Country
5.4 North America Gelatin Based Market by Country
5.5 North America Collagen Based Market by Country
5.6 North America Others Market by Country

Chapter 6. North America Hemostats Market by Country
6.1 US Hemostats Market
6.1.1 US Hemostats Market by Application
6.1.2 US Hemostats Market by Formulation
6.1.3 US Hemostats Market by Type
6.2 Canada Hemostats Market
6.2.1 Canada Hemostats Market by Application
6.2.2 Canada Hemostats Market by Formulation
6.2.3 Canada Hemostats Market by Type
6.3 Mexico Hemostats Market
6.3.1 Mexico Hemostats Market by Application
6.3.2 Mexico Hemostats Market by Formulation
6.3.3 Mexico Hemostats Market by Type
6.4 Rest of North America Hemostats Market
6.4.1 Rest of North America Hemostats Market by Application
6.4.2 Rest of North America Hemostats Market by Formulation
6.4.3 Rest of North America Hemostats Market by Type

Chapter 7. Company Profiles
7.1 Becton, Dickinson and Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Baxter International, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.3 B. Braun Melsungen AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.4 Teleflex, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Medtronic PLC
7.5.1 Company overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.6 SWOT Analysis
7.6 Johnson & Johnson
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental &Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Geographical Expansions:
7.6.6 SWOT Analysis
7.7 Pfizer, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional & Segmental Analysis
7.7.4 Research & Development Expense
7.8 Stryker Corporation
7.8.1 Company Overview
7.8.2 Financial Analysi9
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Integra LifeSciences Holdings Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental & Regional Analysis
7.9.4 Research & Development Expenses
7.10. Artivion, Inc. (CryoLife, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities